Phenomicshealth

Phenomics Health Inc. operates as a bioinformatics-based precision medicine company, established in 2018 by co-founders James S. Burns and Brian D. Athey. Headquartered in Plymouth, Michigan, the firm focuses on translating complex medical big data, including genetics and epigenetics, into actionable clinical treatment decision support tools for healthcare providers. The company's core offering is its proprietary AI-driven platform, which analyzes patient-specific data to help clinicians optimize medication selection and dosage. This technology addresses critical issues in healthcare such as adverse drug reactions (ADRs), patient adherence, and polypharmacy—the simultaneous use of multiple drugs.

The company's primary product, the PredictMed Platform, utilizes artificial intelligence and machine learning to analyze drug-gene interactions, patient drug response, and potential side effects. It aims to provide a comprehensive view of a patient's medication profile by not only predicting responses based on genetics but also by directly measuring medication levels in a patient's system. This dual approach allows healthcare providers to more accurately assess medication adherence and interactions. In November 2019, Phenomics Health acquired the patented pharmacometabolomic technology portfolio from Precera Bioscience, enhancing its platform's capabilities to measure over 200 medications in a patient's bloodstream. This service is intended to be licensed to clinical laboratories and healthcare systems.

Phenomics Health serves healthcare providers and health systems, aiming to improve patient outcomes and reduce costs associated with ineffective medication therapy and adverse reactions. The company has secured $11.5 million in a Series A funding round on October 28, 2022, to support its expansion and further product development. The discoveries that form the basis of the company's technology originated from the University of Michigan Medical School, with which it has exclusive license agreements. The firm also utilizes its platform to support clinical trials through patient-trial matching and safety analytics.

Keywords: precision medicine, bioinformatics, clinical decision support, pharmacogenomics, pharmacometabolomics, AI in healthcare, medication therapy management, drug discovery, genetic testing, adverse drug reaction prevention, polypharmacy, big data analytics, health technology, clinical trials, patient data analysis, treatment optimization, healthcare software, life sciences, venture capital-backed, multi-omics